1. Home
  2. BHF vs LGND Comparison

BHF vs LGND Comparison

Compare BHF & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brighthouse Financial Inc.

BHF

Brighthouse Financial Inc.

N/A

Current Price

$50.37

Market Cap

3.7B

Sector

Finance

ML Signal

N/A

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

N/A

Current Price

$284.85

Market Cap

3.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BHF
LGND
Founded
2016
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.7B
IPO Year
2018
1997

Fundamental Metrics

Financial Performance
Metric
BHF
LGND
Price
$50.37
$284.85
Analyst Decision
Hold
Strong Buy
Analyst Count
8
7
Target Price
$57.71
$256.29
AVG Volume (30 Days)
945.0K
157.1K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
23.06
2886.36
EPS
2.84
1.63
Revenue
$6,766,000,000.00
$141,102,000.00
Revenue This Year
$27.10
$1.25
Revenue Next Year
$1.09
$19.41
P/E Ratio
$18.01
$176.72
Revenue Growth
43.23
29.48
52 Week Low
$44.65
$161.82
52 Week High
$66.80
$326.63

Technical Indicators

Market Signals
Indicator
BHF
LGND
Relative Strength Index (RSI) 26.76 50.98
Support Level N/A $286.99
Resistance Level $63.74 $317.49
Average True Range (ATR) 1.44 8.03
MACD 0.09 0.64
Stochastic Oscillator 22.77 83.11

Price Performance

Historical Comparison
BHF
LGND

About BHF Brighthouse Financial Inc.

Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are: Annuities, that derives majority of the revenue, includes variable, fixed, index-linked, and income annuities; The life segment includes variable, term, universal, and whole life policies; The Run-off segment consists of products that are no longer actively sold and are separately managed, including ULSG, structured settlements, pension risk transfer contracts, certain company-owned life insurance policies and certain funding agreements; and The Corporate & Other segment consists of activities related to funding agreements associated with the company.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: